flanders.bio

Welcome to our new member Muna Therapeutics! Muna Therapeutics discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s and Parkinson’s. The company focuses its groundbreaking science on identifying new medicines to preserve cognition and other brain functions, enhance resilience to disease pathology, and slow or stop the progression of neurodegenerative diseases.

mdxhealth, a commercial-stage precision diagnostics company, today announced the appointment of Dr. Sanford Siegel, M.D. to its Board of Directors. Dr. Siegel has more than 45 years of experience as a practicing urologist and over 35 years of executive leadership experience.

NEWS ALERT: Patrik De Haes is the new CEO of our organisation ! Patrik: "I look forward to working with the team, our members, and the Board of Directors. Together, we will continue to strengthen Flanders' position as a #lifesciences industry leader." We wish Patrik much success in his new role and are confident he will do fantastic work. He succeeds Wouter Piepers, who has led flanders.bio since May 2022. We are also saying goodbye to Willem Dhooge, our COO, who will soon embark on a new adventure. We want to thank both Wouter and Willem for their hard work and dedication in the past years. They will continue to support our organisation with advice in the coming months. You can read the full press release on our website: https://lnkd.in/eDPx6fpr

🌟 Exciting News! 🌟 We are over the moon to welcome flanders.bio as a new partner in the #BTrust project! 🎉 🧬 flanders.bio has been supporting Flemish/Belgian R&D biotech companies for 20 years by fostering a collaborative ecosystem. They excel in networking, training, internationalisation, and providing essential services to create a globally impactful life sciences community. 🌐 Their extensive experience and strong connections will be invaluable in garnering support for the co-creation programme, reducing investment risk, and organising events and maximising the Forum’s potential. flanders.bio prioritises practicality and effectiveness, ensuring tangible results and sustained impact, and we couldn't be happier to have them onboard. 🔬🤝 Join us in celebrating this exciting partnership! 🚀✨ This project is funded by the European Union's Horizon Europe programme 2021-2027.

At this year’s edition of Knowledge for Growth, several key industry leaders shared their innovative solutions, showcasing the transformative power of biotechnology in the food industry: 🌱 Timothy Lefeber, Research Manager at Flanders' FOOD, led this insightful discussion highlighting how innovative solutions are revolutionizing the industry, addressing sustainability challenges, and enhancing food production and safety. 🍋 Timo Van Vooren, Business Development and Product Manager at CITRIBEL, detailed Citribel’s revolutionary development of mycelium-based products, reducing antibiotic use in aquaculture and pet food. 🐟 CEO and co-founder of Fishway Nina Coolsaet shared their innovative approach to cultivated fish, offering a sustainable alternative to traditional fish farming and providing a controlled, pollution-free method to produce fish ingredients with enhanced health benefits. Together, we continue to push the boundaries of what’s possible in the food industry with biotechnology. Thank you to all our participants for their inspiring contributions and dedication to driving positive change! Check out the full interviews for more: 🌟 https://lnkd.in/eWZE9atc #SustainableFood #Biotech #Innovation #KnowledgeForGrowth #KfG2024

SwiftPharma announces that its participation in the groundbreaking €41 million project, PharmECO - Advancing Safe and Sustainable by Design Practices in Pharmaceutical Manufacturing, has officially been approved. This initiative is set to revolutionize pharmaceutical manufacturing by: ▶ implementing cutting-edge, sustainable, and scalable manufacturing technologies ▶ establishing harmonized environmental sustainability assessment systems for pharmaceuticals and biopharmaceuticals To achieve the ambitious goals of this project, SwiftPharma will join forces with 30 esteemed international partners, including universities, research institutes, governmental bodies, SMEs, and major pharmaceutical companies, each bringing their unique expertise.

Welcome to our new member LiveLunger! LiveLunger is a young startup (°2024) in Ghent active in developing telemonitoring solutions for self-management of patients with diseases of the respiratory system. LiveLunger's ambitions are to globally, significantly push the current state-of-the-art in home monitoring and take LiveLunger far beyond the competition.

Trince, a Ghent University (Universiteit Gent) spin-off, announces that it has been nominated for the final of the prestigious Nature Magazine Spinoff Prize. This prize awards spinoff companies that translate innovative research in life sciences and physical sciences into practical solutions with significant social impact.

Last Thursday, flanders.bio hosted its annual general assembly. As we celebrate our 20th anniversary in 2024, we chose to hold the meeting at the Kasteel van Zwijnaarde, paying homage to the iconic location where it all began in 2004. We were delighted to welcome a select group of members and partners, creating a vibrant mix of quality information, company pitches, and an engaging panel discussion on ecosystem hot topics led by our esteemed flanders.bio board members. The meeting was concluded with a meet and greet during a sunny BBQ. The support for the team’s achievements, plans, and enthusiastic candidate presentations for the 2024 Board elections was heartening. Thank you for that! 🙏 We proudly welcome and reintroduce the following members to our renewed Board of Directors (BOD): 2 Bridge (Ann Meulemans), Montis Biosciences (GIL BEYEN), QbD Group (Bart Van Acker) and PMV (Kenneth W.). Together with all members and partners, we aim to strengthen the biotech and life sciences ecosystem even further! On behalf of the BOD and management, we extend our heartfelt gratitude to our outgoing BOD member etherna (Bernard Sagaert). His years of support and valuable advice have been instrumental to flanders.bio and the entire ecosystem. We assure you that the etherna family will remain close to our life sciences heart. Thank you to all who attended. flanders.bio eagerly anticipates a successful continuation in 2024 and beyond. Wishing you all an excellent summer! ☀️🌿 #ecosystembuilding #biotechnology #lifesciences #health #agrifoodtech #flandersbio #20years #flanders #belgium

At this year’s edition of Knowledge for Growth, we were thrilled to highlight some of the most impactful contributions from key players in the biotech ecosystem. Together, we continue to push the boundaries of biotech and sustainable agriculture: 🚀 Jerome Van Biervliet, Managing Director of VIB, shared insights into VIB’s pivotal role as an academic research institute in Flanders. VIB has been instrumental in launching 37 biotech companies, including the impressive Aphea.Bio. 🌱 CEO and co-founder Isabel Vercauteren of Aphea.Bio shared their inspiring journey from their beginnings in 2017 to a thriving company dedicated to sustainable agriculture through microbial products, emphasizing the importance of collaboration with VIB and other stakeholders in driving innovation. Together, we continue to push the boundaries of what’s possible in the agriculture industry with biotechnology. Thank you to all our participants for their inspiring contributions and dedication to driving positive change! Check out the full interview for more: 🌟 https://lnkd.in/efs-Mzuy #SustainableAgriculture #Biotech #Innovation #KnowledgeForGrowth #KfG2024